paj_banner

khoom

YDL223C (HBT1) hmoov chaw tsim tshuaj paus CAS No.: 489408-02-8 99% purity min. rau cov khoom xyaw ntxiv

Lus piav qhia luv luv:

HBT1 khi rau ligand-binding domain ntawm α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R) nyob rau hauv glutamate-dependent yam.


Product Detail

Khoom cim npe

Product Video

Khoom Parameters

Khoom npe

HBT1

Lwm lub npe

YDL 223C

CAS Nr.

489408-02-8

Cov mis mos molecular

C16H17F3N4O2S

Molecular hnyav

386.40 Nws

Purity

99.0%

Qhov tshwm sim

Lub teeb daj khoom

Ntim

1kg rau ib lub hnab 25kg ib nruas

Daim ntawv thov

nootropics

Khoom taw qhia

HBT1 khi rau ligand-binding domain ntawm α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R) nyob rau hauv glutamate-dependent yam. Qhov no txhais tau hais tias HBT1 yog ib qho molecule uas tsuas yog khi rau ib qho chaw tshwj xeeb ntawm AMPA-R protein thaum muaj glutamate, thiab qhov kev khi no pab tswj cov haujlwm ntawm cov protein. AMPA receptors tau nthuav tawm thoob plaws hauv lub hauv nruab nrab lub paj hlwb thiab ua lub luag haujlwm tseem ceeb hauv kev sib txuas lus neuronal, kev hnov ​​​​lus, kev kawm, nco, thiab synaptic plasticity. AMPA receptors yog cov neeg txhawb nqa loj rau excitatory neurotransmission, kho kom haum xeeb sai, sai desensitizing excitation ntawm ntau synapses, thiab koom nrog cov lus teb ntxov rau glutamate hauv thaj tsam synaptic. AMPA receptors feem ntau qhia nrog NMDA receptors ntawm synapses, thiab ua ke lawv txhawb cov txheej txheem synaptic plasticity koom nrog hauv kev kawm, nco, excitotoxicity, thiab neuroprotection. Brain-derived neurotrophic factor (BDNF) yog ib qho tseem ceeb ntawm neurotrophic uas ua lub luag haujlwm tseem ceeb hauv kev saib xyuas thiab nthuav dav ntawm cov neurons thiab muaj zog thiab ntau yam cuam tshuam rau kev loj hlob, sib txawv, ciaj sia taus thiab tuag ntawm cov hlwb thiab tsis yog neuronal. , ib tug neurotransmitter modulator uas txhawb nqa neuronal plasticity hauv kev kawm thiab kev nco. Yog li ntawd, nws yog ib qho tseem ceeb rau kev noj qab haus huv thiab kev noj qab haus huv ntawm lub paj hlwb.

Feature

(1) High purity: HBT1 tuaj yeem tau txais cov khoom siv purity siab los ntawm cov txheej txheem ntau lawm. High purity txhais tau hais tias bioavailability zoo dua thiab tsawg dua qhov tsis zoo.

(2) Kev Nyab Xeeb: HBT1 tau raug pov thawj tias muaj kev nyab xeeb rau tib neeg lub cev.

(3) Kev ruaj ntseg: HBT1 muaj kev ruaj ntseg zoo thiab tuaj yeem tswj hwm nws cov haujlwm thiab cov txiaj ntsig hauv ib puag ncig sib txawv thiab kev cia khoom.

Daim ntawv thov

HBT1 yog ib qho tshiab AMPA receptor enhancer nrog tsawg agonism, uas induces zus tau tej cov hlwb-derived neurotrophic yam (BDNF) thiab muaj tsawg agonistic cuam tshuam rau thawj neurons. HBT1 khi rau ligand-binding domain ntawm AMPA-R nyob rau hauv ib tug glutamate-dependent yam. Ua ke, lawv txhawb cov txheej txheem synaptic plasticity koom nrog hauv kev kawm, nco, excitability, thiab neuroprotection. Nws tuaj yeem txhim kho lub hlwb kev txawj ntse thiab kev nco, thiab txhim kho tib neeg txoj kev muaj peev xwm kawm. Nws yog feem ntau ntxiv rau cov khoom noj txhua hnub hauv daim ntawv ntawm cov khoom noj khoom haus.


  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb